长沙招聘

1. Develop, educate and manage relationship with KOLs and conduct KOL activities
2. Track, analyze and reports targeting KOLs advocacy, contribution and publication status in required system and KOL management tool as ap- propriate
3. Scientific support of speaker training activities in BUs with timely feedback and manage unsolicited requests/objections comply with NP4 and China legal and regulatory requirements
4. Tailor and adapt speaker slides in alignment with NP4 and GCR Brand strategies
5. Provide training to FF and support FF in hospital listing and launch activities. Provide up-to-date medical support to facilitate RDL, formularies as appropriate
6. Support clinical trial preparation and management
7. Main function as the Novartis medical speaker to present at Novar- tis/Society sponsored activities for up-to-date data based scientific and clinical information on Novartis products
8. Conduct or coordinate third party trials/animal studies/Registry pro- grams/research fund raised and funded by GCPO as a KOL develop-ment tools to build advocate and partnership
9. Coach and provide guidance to the staff to be compliant: "
" Clinical bachelor degree or higher (preferable with 2 years of clinical practice experience)
Be considered as peer of the customer base.
MD,PharmD, Pharmacist, PHD and other life sciences with solid medical/technical background and proven competencies influencing skills, clinical research insight, business and market knowledge "
Fluent in Chinese and English (Oral and written) "
1.Thorough knowledge of clinical medicine, disease management and medical research in at least one therapeutic area
2. Ability to synthesize recent scientific information, analyze within strategic and regulatory settings
3..Strong personal integrity, and customer focus
4. Strong communication skill

北京诺华制药有限公司开发、生产和销售治疗多种疾病的创新处方药，涵盖的疾病领域包括：心血管、内分泌、肿瘤、抗感染、风湿疼痛及骨质疏松、移植免疫、中枢神经以及眼科。北京诺华制药曾获得“***雇主”和“最负社会责任的企业”等殊荣。

“诺华”中文取意“承诺中华”，即承诺通过不断创新的产品和服务致力于提高中国人民的健康水平和生活质量。北京诺华制药成立于1987年，总部设在北京，隶属于瑞士诺华公司。

诺华公司致力于为患者及社会提供创新医药保健解决方案，以满足其日益变化的健康需求。2011年，集团持续经营业务实现净销售586亿美元。集团研发投入约为96亿美元（去除减值及摊销后为92亿美元）。诺华集团总部位于瑞士巴塞尔，业务遍及全球140多个国家和地区，拥有124,000位全职员工。诺华集团立足在中国的长期发展，重要战略投资包括位于上海的综合性生物医学研发中心，以及位于北京昌平的制剂生产工厂和江苏常熟的原料药生产工厂。如需更多信息，敬请登录公司网站http://www.novartis.com和http://www.novartis.com.cn。